One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

被引：0
|
作者：
Lei Shi
You Zheng
Zhi Cheng
Ningfei Ji
Changming Niu
Yan Wang
Tingrong Huang
Ruyou Li
Mao Huang
Xiaolin Chen
Lei Shu
Mingjing Wu
Kaili Deng
Jing Wei
Xueli Wang
Yang Cao
Jiaxin Yan
Ganzhu Feng
机构：
[1] the Second Affiliated Hospital of Nanjing Medical University,Department of Pulmonary and Critical Medicine
[2] Huangshi Hospital of Traditional Chinese Medicine,Department of Nephrology
[3] the Second Affiliated Hospital of Nanjing Medical University,Department of Critical Care Medicine
[4] The First Affiliated Hospital of Nanjing Medical University,Department of Respiratory and Critical Care Medicine
[5] Jiangsu Cell Tech Medical Research Institute,Department of Respiratory Medicine
[6] Huangshi Central Hospital,Department of Pulmonary and Critical Care Medicine
[7] the Second Affiliated Hospital of Nanjing Medical University,Department of Respiratory Medicine, Sir Run Run Hospital
[8] Nanjing Medical University,undefined
来源：
Stem Cell Research & Therapy | / 13卷
关键词：
Coronavirus disease 2019 (COVID-19); Human umbilical cord mesenchymal stem cells (h-UC-MSCs); 1-Year follow-up; Sequelae; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 27 条
  • [21] Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina - Final 3-year follow-up
    Mathiasen, Anders Bruun
    Haack-Sorensen, Mandana
    Jorgensen, Erik
    Kastrup, Jens
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 170 (02) : 246 - 251
  • [22] Bone marrow mesenchymal stem cell and mononuclear cell combination therapy in patients with type 2 diabetes mellitus: a randomized controlled study with 8-year follow-up
    Wu, Zhixian
    Huang, Shulin
    Li, Shasha
    Cai, Jinquan
    Huang, Lianghu
    Wu, Weizhen
    Chen, Jin
    Tan, Jianming
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [23] The Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan
    Zhang, Jun
    Shu, Tingting
    Zhu, Rui
    Yang, Fengwen
    Zhang, Boli
    Lai, Xuefeng
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [24] Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up
    Wu, Zhixian
    Xu, Xiumin
    Cai, Jinquan
    Chen, Jin
    Huang, Lianghu
    Wu, Weizhen
    Pugliese, Alberto
    Li, Shasha
    Ricordi, Camillo
    Tan, Jianming
    CYTOTHERAPY, 2022, 24 (04) : 421 - 427
  • [25] Post-sequelae one year after hospital discharge among older COVID-19 patients: A multi-center prospective cohort study
    Fang, Xiaoyu
    Ming, Chao
    Cen, Yuan
    Lin, Hao
    Zhan, Kegang
    Yang, Sha
    Li, Li
    Cao, Guoqiang
    Li, Qi
    Ma, Xiangyu
    JOURNAL OF INFECTION, 2022, 84 (02) : 179 - 186
  • [26] Consistently lower narcotics consumption after video-assisted thoracoscopic surgery for early stage non-small cell lung cancer when compared to open surgery: a one-year follow-up study
    Fang, Hsin-Yuan
    Chen, Chih-Yi
    Wang, Yao-Ching
    Wang, Pin-Hui
    Shieh, Shwn-Huey
    Chien, Chun-Ru
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (04) : 783 - 786
  • [27] Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study in China
    Mo, Xinyuan
    Men, Zhaoyue
    Gao, Linying
    Gao, Yizhuo
    Yao, Tian
    Liu, Yuan
    Yuan, Yuan
    Xue, Tongchuan
    Wang, Fuzhen
    Wang, Suping
    Wang, Keke
    Liang, Xiaofeng
    Feng, Yongliang
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
123